Increased fracture frequency in adult patients with hypopituitarism and GH deficiency

European Journal of Endocrinology

Volumn 137, Issue 3, 1997, Pages 240-245

  Rosén, Thord ^a   Wilhelmsen, Lars ^a   Landin Wilhelmsen, Kerstin ^a   Lappas, Georg ^a   Bengtsson, Bengt Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; ESTRADIOL; HUMAN GROWTH HORMONE; LEVOTHYROXINE; TESTOSTERONE;

ADULT; AGED; ARTICLE; BONE MASS; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; FEMALE; FRACTURE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOPITUITARISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; FEMALE; FRACTURES, BONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; ODDS RATIO; SEX CHARACTERISTICS; THYROXINE;

EID: 0030882291     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370240     Document Type: Article

References (26)

1. Kaufman J-M, Taelman P, Vermeulen A & Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. Journal of Clinical Endocrinology and Metabolism 1992 74 118-123.
2. Rosén T, Hansson T, Granhed H, Szücs J & Bengtsson B-Å. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinologica 1993 129 201-208.
3. Wüster CHR, Slenczka E & Ziegler R, Erhöhte Prävalenz von Osteoporose und Arteriosklerose bei konventionell substituierter Hypophysenvorderlappeninsuffizienz: Bedarf einer zusätzlichen Wachstumshormonsubstitution? Klinischer Wochenschrift 1991 69 769-773.
4. Kuulasmaa K. WHO MONICA Project: Risk factors. International Journal of Epidemiology 1989 18 (Suppl 1) 46-65.
5. Beard CM, Melton LJ, Cedel SL, Richelsen LS & Riggs BL. Ascertainment of risk factors for osteoporosis: comparison of interview date with medical records. Journal of Bone and Mineral Research 1990 5 691-699.
6. Riggs BL. Textbook of Endocrinology, edn 2. Ed LJ Degroot. Orlando: Grune and Stratton. 1987.
7. Bengnér U. Age-related fractures. Epidemiological changes over 30 years in an urban population. Thesis. Sweden: University of Malmö, 1987.
8. Rosén T, Edén S, Larson G, Wilhelmsen L & Bengtsson B-Å. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinologica 1993 129 195-200.
9. Cooper C, Barker DJ & Wickham C. Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain. British Medical Journal 1988 297 1443-1446.
10. Rosén T, Wirén L, Wilhelmsen L, Wiklund I & Bengtsson B-Å. Decreased psychological well-being in adult patients with growth hormone deficiency. Clinical Endocrinology 1994 40 111-116.
11. Jörgensen JOL, Pedersen SA, Thuesen L, Jörgensen J, IngemannHansen T, Skakkebaek NE & Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989 i 1221-1225.
12. Hahn TJ. Corticosteroid-induced osteopenia. Archives of Internal Medicine 1978 138 882-885.
13. Kung AWC & Pun KK. Bone mineral density in premenopausal women receiving long-term physiological doses of levothyroxine. Journal of the American Medical Association 1991 265 2688-2691.
14. Foresta C, Ruzza A, Mioni R, Guarneri G, Gribaldo R, Meneghei A et al. Osteoporosis and decline of gonadal function in the elderly male. Hormone Research 1984 19 18-22.
15. Jackson JA, Kleerekoper M, Parfitt AM, Rao DS, Villanueva AR & Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal stenosis. Journal of Clinical Endocrinology and Metabolism 1987 65 53-58.
16. Aitken JM, Hart DM & Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. British Medical Journal 1973 3 515-516.
17. Davies MC, Gulekli B & Jacobs HS. Osteoporosis in Turner's syndrome and other forms of primary amenorrhea. Clinical Endocrinology 1995 43 741-746.
18. Isaksson OGP, Lindahl A, Nilsson A & Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocrine Reviews 1987 8 426-438.
19. Bouillon R. Growth hormone and bone. Hormone Research 1991 36 (Suppl 1) 49-55.
20. Brixen K, Kassem M, Fink Eriksen E, Nielsen HK, Flyvberg A & Mosekilde L. Growth hormone (GH) and adult bone remodeling: The potential use of GH in the treatment of osteoporosis. Journal of Paediatric Endocrinology 1993 6 65-71.
21. Stracke H, Schulz A, Rossol R, Moeller D & Schatz H. Effect of growth hormone on osteoblasts and demonstration of somatomedin C/IGF-I in bone organ culture. Acta Endocrinologica 1984 107 16-24.
22. Ernst M, Heath JK & Rodan GA. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I. and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 1989 125 825-833.
23. McCarthy TL, Centrella M, Raisz LG & Canalis E. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1991 128 2895-2900.
24. Linkhart TA & Mohan S. Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 1989 125 1484-1491.
25. McCarthy TL, Centrella M & Canalis E. Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. Endocrinology 1990 126 1569-1575.
26. Rosén T, Johannsson G, Hallgren P, Caidahl K, Bosaeus I & Bengtsson B-Å. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinology and Metabolism 1994 1 55-66.